Biotech Startups

Aqualung Therapeutics is an early-stage therapeutics company developing a drug discovery platform and pipeline focused on advancing human health. It is affiliated with the University of Florida biotech ecosystem.

2 investors

Medical device company developing a Smart External Drain for cerebrospinal fluid drainage and intracranial pressure monitoring.

2 investors

Aquit provides R&D services in bioinformatics, molecular biology, and antibody development to support companies and research centers advancing innovation in aquaculture. The company delivers scientific support including genome analysis and in vitro validation for sustainable alternatives to antibiotics in fish farming.

2 investors

Aradigm develops financial and delivery infrastructure for cell and gene therapies, partnering with payers, providers, manufacturers, and patients to enable sustainable access to transformative treatments through a pass-through business model.

2 investors

Arase Therapeutics develops first-in-class oncology therapeutics that target ADP-ribose Hydrolases, novel proteins in cancer stress pathways. The company focuses on developing new cancer treatments for patients with various cancer types.

2 investors

2 investors

Arborea develops sustainable nutritious food ingredients using biotechnology. The company focuses on building a net-zero, nature-positive food system for global food production.

2 investors

Arcaea develops new technologies and products for the beauty industry, drawing on expertise across the supply chain to create alternatives to existing approaches.

2 investors

Archon Biosciences develops a computational protein design platform leveraging AI and deep learning for therapeutic and vaccine applications. The company was founded in 2023 by James Lazarovits and George Ueda, Ph.D., building on research in AI-driven protein engineering and nanomaterial delivery.

2 investors

Arcomedlab develops personalized medicine implants and drug-releasing systems to improve patient quality of life. The company designs and manufactures medical devices including orthopedic and dental implants using advanced technologies such as 3D printing.

2 investors

Arcoris Bio develops multiplex biomarker detection technology for researchers and clinicians in biomedical research and diagnostics. The company's MUSE technology enables precise, sensitive detection of multiple biomarkers across fields including cancer, immunology, neuroscience, and pharmaceutical research.

2 investors

Arc Therapeutics is a stealth-stage biopharmaceutical company developing medicines for central nervous system (CNS) conditions with high unmet medical needs.

2 investors

Arctoris operates a Partnership Research Organisation that combines automated robotic laboratory technology with scientists to run drug discovery experiments and generate reproducible, FAIR-compliant datasets for life sciences R&D partners. Founded out of the University of Oxford, it serves pharma and biotech teams pursuing novel therapeutics.

2 investors

Arctx Medical develops an investigational cooling therapy device designed to treat acute pancreatitis by reducing pancreatic inflammation through localized temperature control. The company targets patients with acute inflammatory pancreatic disease to prevent progression to systemic illness and organ failure.

2 investors

Ardra uses fermentation technology to produce natural ingredients for food, perfumery, and cosmetics from renewable substrates, offering stable pricing and consistent quality independent of seasonal or geopolitical disruptions. The company's approach eliminates environmental and social costs associated with traditional botanical and animal-derived ingredients.

2 investors

Arevo develops a proprietary crop nutrition technology (Arginex) that activates the plant root zone to improve nutrient uptake, offering growers an alternative to conventional mineral fertilisers. Based on research from the Swedish University of Agricultural Sciences, it serves agricultural producers and formulators seeking to reduce reliance on chemical inputs.

2 investors

Arexera Therapeutics, formerly Atalanta Therapeutics, is a biotechnology company developing small interfering RNA (siRNA) medicines to treat severe neurological diseases, with a franchise focused on Huntington's disease.

2 investors

ArisGlobal provides software for life sciences research and development, covering drug development, drug safety monitoring, and regulatory compliance. It serves biopharmaceutical companies, CROs, and government health authorities, working with over 220 global life sciences organizations.

2 investors

Ark Biosciences is a biopharmaceutical company developing small molecule drugs for infectious diseases, respiratory conditions, neuropsychiatric disorders, and rare diseases. The company has multiple drug candidates in clinical development, with products licensed from partners including Roche and others.

2 investors

Armatus Bio develops vectorized RNA interference therapeutics targeting genetic neurological and neuromuscular diseases.

2 investors

2 investors

Arnatar develops a next-generation RNA discovery platform called DARGER that combines gene silencing and gene upregulation technologies for oligonucleotide therapeutics. The platform serves pharmaceutical researchers and biotechnology companies developing treatments for genetic disorders and other disease areas.

2 investors

Aro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.

2 investors

Arontier is a company that applies artificial intelligence to drug discovery, using proprietary technology and data to develop treatments for incurable and rare diseases. Founded in 2017, it collaborates with companies, experts, and scholars on new medicines and genetic editing.

2 investors